[What have we learned from converting enzyme inhibitors on renin-angiotensin system?]

Détails

ID Serval
serval:BIB_8D7CB8995636
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
[What have we learned from converting enzyme inhibitors on renin-angiotensin system?]
Périodique
Revue du Praticien
Auteur(s)
Waeber  B., Nussberger  J., Brunner  H. R.
ISSN
0035-2640 (Print)
Statut éditorial
Publié
Date de publication
12/1992
Volume
42
Numéro
20
Pages
2529-32
Notes
English Abstract
Journal Article
Review --- Old month value: Dec 15
Résumé
Angiotensin-converting-enzyme (ACE) inhibitors are now widely used to treat patients with high blood pressure or heart failure. The favourable results obtained with these inhibitors of the renin-angiotensin system suggest that angiotensin II has a noxious effect on the development and/or course of these diseases. ACE inhibitors are usually well tolerated. Their most severe side-effects are mostly foreseeable and therefore avoidable. Chronic blockade of the renin-angiotensin system increasingly seems to be a good therapeutic approach to the protection of the vital organs.
Mots-clé
Angiotensin-Converting Enzyme Inhibitors/adverse effects/*pharmacology Humans Peptidyl-Dipeptidase A/*physiology Renin-Angiotensin System/*drug effects/physiology
Pubmed
Création de la notice
05/03/2008 17:40
Dernière modification de la notice
03/03/2018 19:16
Données d'usage